Healthcare -
Biotechnology - NASDAQ - US
$ 21.98
-1.7 %
$ 16.2 B
Market Cap
-95.57
P/E
SMMT - ACCOUNTS PAYABLE
Accounts Payable SMMT - Summit Therapeutics Inc.
2.67 M
LAST VALUE
-21.91%
2 YEAR CAGR
-14.39%
5 YEAR CAGR
16.57%
10 YEAR CAGR